Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · ONESOURCE

ONESOURCE

HealthcarePharmaceuticals & Biotechnology₹18161 cr market cap
₹1609.90 ▲ +1.49% today As of 19 Nov 2026
52-week low ₹1114.0052-week high ₹1867.40

-15.1% from the 52-week high · +42.4% above the low

Onesource Specialty Pharma Ltd develops and distributes niche pharmaceutical products, catering to specialized therapeutic areas. The company integrates research, regulatory compliance, and supply chain management for effective healthcare delivery.

The short version. ONESOURCE reported revenue of ₹449 crore for Jun 2026, up 37.3% from a year earlier. Return on equity was -1.3% in Mar 2026. Promoter holding was 30.47% in Sep 2026, down 7.30 points over 8 quarters.

1 · The price

How has the stock traded?

ONESOURCE trades 15.1% below its 52-week high and 42.4% above its 52-week low.

Change over period: —

1M+16.1%
3M+4.3%
6M-15.1%
1Y-8.1%

2 · The business

Is it growing?

Sales, year on year+37.3%

Jun 2026 revenue of ₹449 cr.

Net margin5.6%

5.7 pts higher than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue44942829037632742639368
Net profit255-8910098-67-39
Net margin %5.61.1-30.62.8-0.123.1-17.1-57.8
EPS (₹)2.180.4-7.740.92-0.028.58-5.85-3.44

Annual

FY2026FY2025
Revenue14221445
Net profit-74-18
Net margin %-5.2-1.2
EPS (₹)-6.44-1.57

3 · The quality

How well does it turn capital into profit?

Return on equity was -1.3% in Mar 2026; debt to equity is 0.22.

Profitability · 2 years

Returns and margins

Mar 2026Mar 2025
Return on equity %-1.3-0.3
Return on capital %0.41.5
EBITDA margin %21.525.5
Net margin %-5.1-1.2

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.22
Interest cover0.3x
Current ratio0.99

4 · The owners

Who holds it, and are they adding?

Promoter holding30.47%

Down 7.3 pts over 8 quarters.

Foreign institutions19.46%

Up 2.02 pts over 8 quarters.

Domestic institutions24.21%

Up 11.65 pts over 8 quarters.

Mutual fund schemes101

+28 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter37.7734.2529.7929.7729.9330.4830.4830.47-7.3
FII17.4418.5418.6919.3919.2417.519.1919.46+2.02
DII12.5618.0418.118.4918.8120.6123.3824.21+11.65
Public32.2329.1733.4232.3532.0231.4126.9425.86-6.37

Mutual fund holdings · Oct 2026

101 schemes hold this stock

73 the month before.

  • JM Focused Fund4.3% of NAV
  • Motilal Oswal ELSS Tax Saver Fund3.65% of NAV
  • Motilal Oswal Large and Midcap Fund3.04% of NAV
  • Mirae Asset Healthcare Fund3.04% of NAV
  • Motilal Oswal Special Opportunities Fund3.03% of NAV
  • Motilal Oswal Flexicap Fund2.92% of NAV
  • Motilal Oswal Active Momentum Fund2.59% of NAV
  • 360 ONE Focused Fund2.55% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for ONESOURCE are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about ONESOURCE

What is the ONESOURCE share price?

ONESOURCE (ONESOURCE) last closed at ₹1,609.90, up 1.49% on the day. Its 52-week range is ₹1,114.00 to ₹1,867.40.

What is the market cap of ONESOURCE?

ONESOURCE has a market capitalisation of about ₹18,161 crore.

How are ONESOURCE's latest results?

ONESOURCE reported revenue of ₹449 crore for Jun 2026, up 37.3% from a year earlier. Return on equity was -1.3% in Mar 2026. Promoter holding was 30.47% in Sep 2026, down 7.30 points over 8 quarters.

Who owns ONESOURCE?

As of Sep 2026, shareholding was: Promoter 30.47%, FII 19.46%, DII 24.21%, Public 25.86%.

How many mutual funds hold ONESOURCE?

101 mutual fund schemes held ONESOURCE in October 2026. That compares with 73 the month before.

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.